Technical Analysis for KALV - KalVista Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 18.15 -3.97% -0.75
KALV closed down 3.97 percent on Thursday, January 17, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical KALV trend table...

Date Alert Name Type % Chg
Jan 17 MACD Bearish Signal Line Cross Bearish 0.00%
Jan 17 Down 3 Days in a Row Weakness 0.00%
Jan 16 Fell Below 20 DMA Bearish -3.97%
Jan 16 Multiple of Ten Bearish Other -3.97%
Jan 15 20 DMA Support Bullish -7.35%
Jan 15 Multiple of Ten Bearish Other -7.35%
Jan 14 20 DMA Support Bullish -9.20%
Jan 14 Pocket Pivot Bullish Swing Setup -9.20%
Jan 14 Multiple of Ten Bearish Other -9.20%
Jan 11 50 DMA Resistance Bearish -8.15%

Older signals for KALV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The Company is developing a plasma kallikrein inhibitor, which is administered directly into the eye. The Company is engaged in advancing several product candidates developed from its portfolio into early clinical trials. The Company is progressing additional oral candidates towards regulatory preclinical studies. The Company's HAE product candidate, KVD818, is an inhibitor of plasma kallikrein. The Company has initiated clinical testing of KVD818 in a Phase I clinical trial. It has completed an open-label single ascending dose Phase I trial in DME patients with KVD001.
Is KALV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.57
52 Week Low 7.73
Average Volume 60,879
200-Day Moving Average 14.5043
50-Day Moving Average 20.321
20-Day Moving Average 19.1955
10-Day Moving Average 19.647
Average True Range 1.4691
ADX 14.1
+DI 13.6804
-DI 19.6594
Chandelier Exit (Long, 3 ATRs ) 18.4827
Chandelier Exit (Short, 3 ATRs ) 21.3573
Upper Bollinger Band 21.0687
Lower Bollinger Band 17.3223
Percent B (%b) 0.22
BandWidth 19.517074
MACD Line -0.3822
MACD Signal Line -0.3144
MACD Histogram -0.0678
Fundamentals Value
Market Cap 176.29 Million
Num Shares 9.71 Million
EPS -3.07
Price-to-Earnings (P/E) Ratio -5.91
Price-to-Sales 202.03
Price-to-Book 4.72
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.86
Resistance 3 (R3) 20.00 19.57 19.58
Resistance 2 (R2) 19.57 19.13 19.50 19.48
Resistance 1 (R1) 18.86 18.87 18.65 18.72 19.38
Pivot Point 18.43 18.43 18.32 18.36 18.43
Support 1 (S1) 17.72 17.99 17.51 17.58 16.92
Support 2 (S2) 17.29 17.73 17.22 16.82
Support 3 (S3) 16.58 17.29 16.73
Support 4 (S4) 16.44